Welcome to our dedicated page for PREFERRED COMMERCE news (Ticker: CELV), a resource for investors and traders seeking the latest updates and insights on PREFERRED COMMERCE stock.
Preferred Commerce Inc, based in the United States, is the parent company of Cellev8, a pioneering supplement brand. Cellev8 recently achieved NSF Certified for Sport certification, making it the first supplement company to do so. This certification ensures the quality and safety of Cellev8 products, particularly its SOD-based gummy, which supports athletes in enhancing recovery, performance, and overall well-being.
Cellev8's unique formula includes Superoxide Dismutase (SOD), a powerful antioxidant enzyme that neutralizes free radicals and reduces oxidative stress. The NSF for Sport Certification signifies that Cellev8 has met and exceeded the stringent standards set by NSF International, making it a trusted choice for athletes at all levels.
Cellev8 and Zyppah have announced a collaborative sales agreement targeting 90 million Americans affected by snoring. The partnership combines Cellev8's SOD-based inflammation and recovery gummies with Zyppah's anti-snoring devices. The global anti-snoring devices market, valued at $1.52 billion in 2022, is projected to reach $2.65 billion by 2030. Undiagnosed sleep apnea costs the U.S. economy approximately $149.6 billion annually. The joint offering will be available starting November 1, 2024, through both companies' websites with specific discount codes and subscription models.
FAQ
What is the market cap of PREFERRED COMMERCE (CELV)?
What is Cellev8?
What is the significance of NSF Certified for Sport certification for Cellev8?
What is Superoxide Dismutase (SOD) and why is it important in Cellev8 products?
What sets Cellev8 apart in the sports nutrition industry?
Who is Michael Ferraro and what is his role in Cellev8?
